©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 7, 2023; 29(1): 157-170
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies
Tawfik Khoury, Wisam Sbeit, Department of Gastroenterology, Galilee Medical Center, Nahariya 2210001, Israel
Bertrand Napoléon, Department of Endoscopy Unit, Private Hospital Jean Mermoz, Lyon 69008, France
Author contributions: Napoléon B and Khoury T contributed to study design; all authors contributed to the data collection; Napoléon B and Khoury T contributed to the critical revision of the manuscript; and all authors approved the final version to be published.
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
Corresponding author: Tawfik Khoury, MD, Assistant Professor, Doctor, Senior Lecturer, Department of Gastroenterology, Galilee Medical Center, Meona Street, Nahariya 2210001, Israel. tawfikkhoury1@hotmail.com
Received: September 26, 2022
Peer-review started: September 26, 2022
First decision: October 18, 2022
Revised: October 21, 2022
Accepted: December 13, 2022
Article in press: December 13, 2022
Published online: January 7, 2023
Processing time: 99 Days and 14.7 Hours
Peer-review started: September 26, 2022
First decision: October 18, 2022
Revised: October 21, 2022
Accepted: December 13, 2022
Article in press: December 13, 2022
Published online: January 7, 2023
Processing time: 99 Days and 14.7 Hours
Core Tip
Core Tip: Endoscopic ultrasound guided radiofrequency ablation has been increasingly implemented in the treatment of pancreatic neoplasms. We reviewed the role of endoscopic ultrasound guided radiofrequency ablation in the treatment of pancreatic neuroendocrine tumors, unresectable pancreatic adenocarcinoma, and pancreatic cystic lesions, focusing on efficacy, safety, and controversies. We found that endoscopic ultrasound guided radiofrequency ablation was feasible with an excellent technical success, acceptable adverse events, and a beneficial effect for pancreatic neuroendocrine tumors, mainly on insulinoma. While its effect on pancreatic adenocarcinoma and cystic lesions is promising, more studies are needed to better explore its role.